GlioMesh: A Drug‐Eluting 3D‐Printed Mesh (GlioMesh) for Management of Glioblastoma (Adv. Therap. 11/2019)

Abstract

In article 1900113 Mohsen Akbari and co‐workers develop a hydrogel‐based mesh containing temozolomide‐loaded poly(lactic‐co‐glycolic acid) microspheres with high encapsulation efficiency (GlioMesh) that can release anticancer drugs directly at a tumor site. GlioMesh can conform to the irregular structure of brain tissue because of its flexibility and release drugs for up to two months.